These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24503277)

  • 1. End-stage renal disease associated with prophylactic lithium treatment.
    Aiff H; Attman PO; Aurell M; Bendz H; Schön S; Svedlund J
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):540-4. PubMed ID: 24503277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of modern treatment principles may have eliminated lithium-induced renal failure.
    Aiff H; Attman PO; Aurell M; Bendz H; Schön S; Svedlund J
    J Psychopharmacol; 2014 Feb; 28(2):151-4. PubMed ID: 24346809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure occurs in chronic lithium treatment but is uncommon.
    Bendz H; Schön S; Attman PO; Aurell M
    Kidney Int; 2010 Feb; 77(3):219-24. PubMed ID: 19940841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal replacement therapy associated with lithium nephrotoxicity in New Zealand.
    Wells JE; Cross NB; Savage RL; Parkin L; Horsburgh S; Richardson AK
    N Z Med J; 2015 Nov; 128(1425):77-83. PubMed ID: 26905990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal replacement therapy associated with lithium nephrotoxicity in Australia.
    Roxanas M; Grace BS; George CR
    Med J Aust; 2014 Mar; 200(4):226-8. PubMed ID: 24580527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study.
    Kessing LV; Gerds TA; Feldt-Rasmussen B; Andersen PK; Licht RW
    JAMA Psychiatry; 2015 Dec; 72(12):1182-91. PubMed ID: 26535805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry.
    Wühl E; van Stralen KJ; Wanner C; Ariceta G; Heaf JG; Bjerre AK; Palsson R; Duneau G; Hoitsma AJ; Ravani P; Schaefer F; Jager KJ
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv1-8. PubMed ID: 25165174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decision analysis of long-term lithium treatment and the risk of renal failure.
    Werneke U; Ott M; Renberg ES; Taylor D; Stegmayr B
    Acta Psychiatr Scand; 2012 Sep; 126(3):186-97. PubMed ID: 22404233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End stage renal disease in Brunei Darussalam - report from the first Brunei Dialysis Transplant Registry (BDTR).
    Tan J
    Ren Fail; 2013 Sep; 35(8):1101-4. PubMed ID: 23879396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival trends in ESRD patients compared with the general population in the United States.
    van Walraven C; Manuel DG; Knoll G
    Am J Kidney Dis; 2014 Mar; 63(3):491-9. PubMed ID: 24210591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal replacement therapy due to type 1 diabetes; time trends during 1995-2010--a Swedish population based register study.
    Toppe C; Möllsten A; Schön S; Jönsson A; Dahlquist G
    J Diabetes Complications; 2014; 28(2):152-5. PubMed ID: 24332762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in renal replacement therapy in Turkey, 1996-2008.
    Süleymanlar G; Serdengeçti K; Altiparmak MR; Jager K; Seyahi N; Erek E;
    Am J Kidney Dis; 2011 Mar; 57(3):456-65. PubMed ID: 21335249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk for end-stage renal disease is increased after burn.
    Helanterä I; Koljonen V; Finne P; Tukiainen E; Gissler M
    Burns; 2016 Mar; 42(2):316-21. PubMed ID: 26620696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with end stage renal disease: a registry at Sultanah Aminah Hospital, Johor Bahru, Malaysia.
    Liu WJ; Hooi LS
    Med J Malaysia; 2007 Aug; 62(3):197-200. PubMed ID: 18246906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium-induced nephropathy: Rate of progression and prognostic factors.
    Presne C; Fakhouri F; Noël LH; Stengel B; Even C; Kreis H; Mignon F; Grünfeld JP
    Kidney Int; 2003 Aug; 64(2):585-92. PubMed ID: 12846754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.